Yüklüyor......
The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma
The development of several treatment options over the last 2 decades has led to a notable improvement in the survival of patients with multiple myeloma. Despite these advances, the disease remains incurable for most patients. Moreover, standard combinations of alkylating agents, immunomodulatory dru...
Kaydedildi:
| Yayımlandı: | Ther Adv Hematol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8170343/ https://ncbi.nlm.nih.gov/pubmed/34104374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20406207211019622 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|